Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03916809 · ClinicalTrials.gov registry record · NA
EMST in Patients Undergoing CRT for HNCA
A NA study of Head and Neck Neoplasms and Deglutition Disorders, sponsored by University of Wisconsin, Milwaukee.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 2
- Study locations
NCT03916809: Recruiting NA study of Head and Neck Neoplasms and Deglutition Disorders, sponsored by University of Wisconsin, Milwaukee.
NCT03916809 is a NA study of Head and Neck Neoplasms and Deglutition Disorders that is actively recruiting participants, run by University of Wisconsin, Milwaukee. The registered enrollment target is 30 participants, below the 264-participant average among 23 other Head and Neck Neoplasms trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03916809, a NA study of Head and Neck Neoplasms and Deglutition Disorders, is actively recruiting participants, sponsored by University of Wisconsin, Milwaukee.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is a randomized trial examining the impact of expiratory muscle strength training (EMST) on maintenance of safe and efficient oropharyngeal swallow function in persons with cancer of the head and neck (HNCA) undergoing treatment with radiation therapy or chemoradiotherapy (RT/CRT).
Primary Outcome
the number of days from the beginning of the study until change in feeding status from 100% oral intake to combined oral intake and tube intake and/or 100% tube feeding will be calculated
Conditions Studied
Interventions
- OTHER EMST
Study Locations (2)
Wisconsin
- University of Wisconsin Milwaukee - Milwaukee
- Froedtert Hospital - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-07-12 |
| Est. Completion | 2025-08-01 |
| Phase | NA |
What NCT03916809 shows while recruiting
NCT03916809 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 264-participant average among 23 other Head and Neck Neoplasms trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Head and Neck Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which EMST is the first listed.
NCT03916809 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT03916809 about?
NCT03916809 is a clinical study titled "EMST in Patients Undergoing CRT for HNCA". This study is a randomized trial examining the impact of expiratory muscle strength training (EMST) on maintenance of safe and efficient oropharyngeal swallow function in persons with cancer of the head and neck (HNCA) undergoing treatment with radiation therapy or chemoradiotherapy (RT/CRT).
What is the current status of trial NCT03916809?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2017-07-12. Estimated completion is 2025-08-01.
What conditions does trial NCT03916809 study?
This clinical trial studies the following conditions: Head and Neck Neoplasms, Deglutition Disorders.
What interventions are being tested in trial NCT03916809?
The interventions under investigation include: EMST (OTHER).
Who is sponsoring clinical trial NCT03916809?
This trial is sponsored by University of Wisconsin, Milwaukee, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03916809 being conducted?
This trial has 2 study locations across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head and Neck Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03916809's enrollment target sits among peer trials
30 17th of 23 higher than 5 of 23 other Head and Neck Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Head and Neck Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads
RECRUITING · NA
-
Image-guided Cryoablation of Head, Neck and Spine Tumors
COMPLETED · NA
-
Head and Neck Cancer Study Project in the Geriatric Population
RECRUITING · Phase 3
-
NIDCD Otolaryngology Clinical Protocol Biospecimen Bank
RECRUITING
-
A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer
RECRUITING · Phase 2
-
Molecular and Genomic Profiling of Head and Neck Tumors
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI